Stay updated on Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial
Sign up to get notified when there's something new on the Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial page.

Latest updates to the Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page footer now lists Revision: v3.3.3, and the items HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedThe Publications section now states that PubMed publications are automatically filled from PubMed and may not all be about the study. The revision label has been updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check55 days agoChange DetectedRemoved the government funding and operating status banner from the study page; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check76 days agoChange DetectedStudy status updated to Terminated; enrollment difficulties arose as patients opted for ovarian ablation to obtain insurance reimbursement, making them ineligible for participation.SummaryDifference0.4%

- Check98 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference4%

- Check105 days agoChange DetectedUpdate: version tag updated from v3.0.2 to v3.1.0. The page now indicates the newer release.SummaryDifference0.1%

Stay in the know with updates to Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial page.